Search clinical trials for: JNJ-54175446 (suspension)

Total 2182 results

Natasha Appelman-Dijkstra

Recruiting

DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD) (DeFiD)

Fibrous Dysplasia | McCune Albright Syndrome

Netherlands
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne Tablets

Healthy

Taiwan
Janssen Research & Development, LLC

Completed

Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male Participants

Healthy

United States
Janssen Research & Development, LLC

Completed

A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-39439335 in Patients With Osteoarthritis

Osteoarthritis, Knee

South Africa
Janssen Research & Development, LLC

Terminated

A Study of Itraconazole in the Management of Superficial Fungal Infections in India

Mycoses

India
Janssen Research & Development, LLC

Withdrawn

A Study of JNJ-56136379 in Healthy Participants

Healthy
Xian-Janssen Pharmaceutical Ltd.

Withdrawn

Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy Participants

Healthy

China
University of Nebraska
InCor Heart Institute; VU University of Amsterdam

Completed

Microvascular Recovery With Ultrasound in Myocardial Infarction (MRUSMI) Post PCI Trial (MRUSMI)

Chest Pain | STEMI

Netherlands, Brazil
University of North Carolina, Chapel Hill
Flexion Therapeutics, Inc.

Completed

Effect of Zilretta Injection

Osteoarthritis, Knee

United States
FHI 360

Completed

Sayana® Press Extension Study

Contraception

Brazil, Chile, Dominican Republic
General Hospital of Athens Elpis

Completed

Brinzolamide-brimonidine Fixed Combination for Preventing IOP Elevation After Intravitreal Anti-VEGF Injections

Eye Diseases | Intraocular Pressure | Injection Complication

Greece
Verona Pharma plc

Completed

Bronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPD

COPD

United States, United Kingdom
Novo Nordisk A/S

Completed

Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Ural State Medical University
Ural Institute of Cardiology; De Haar Research Foundation

Completed

Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients

Cardiorenal Syndrome | Chronic Allograft Nephropathy

Netherlands, Russian Federation
AstraZeneca
Eli Lilly and Company

Completed

Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy

Type 2 Diabetes Mellitus

Italy, Poland, Hungary, Mexico, Greece, Australia
Pacira Pharmaceuticals, Inc
Registrat-Mapi

Terminated

A Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy (IMPROVE-Lap)

Bowel Obstruction

United States
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica

Allergic Rhinoconjunctivitis

Spain
Kyushu University

Unknown

PEG-IFN Plus Ribavirin Combination Therapy for Older Patients

Hepatitis C Virus

Japan
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma

United States
University of Oklahoma

Recruiting

Effect of Gabapentin on Post-Operative Pain in Minimally Invasive Sacrocolpopexy (GPOP)

Post Operative Pain

United States
Toyos Clinic
Bausch & Lomb Incorporated

Completed

Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%

Inflammation | Pseudophakia
Alcon Research

Completed

24-hr Intraocular Pressure Control With SIMBRINZA ®

Glaucoma
Alcon, a Novartis Company

Completed

LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration

Exudative Age-Related Macular Degeneration

United States
Bristol-Myers Squibb

Completed

BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C

Hepatitis C

United States, Puerto Rico
King Abdulaziz Medical City
King Faisal Specialist Hospital & Research Center; Riyadh Military Hospital

Completed

Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients

Chronic Hepatitis C | Renal Transplant

Saudi Arabia
Alkermes, Inc.

Completed

ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)

Alcoholism
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Healthy
University of Zurich
University Hospital, Geneva; University Hospital Inselspital, Berne; University... and other collaborators

Terminated

Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19

COVID-19 | Pulmonary Embolism, Deep Vein Thrombosis

Switzerland, Germany
University of Texas at Austin

Completed

Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response

Anxiety

United States
Janssen Research & Development, LLC

Completed

A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy Participants

Healthy

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

An Efficacy Study of JNJ-39220675 and Pseudoephedrine in Participants With Allergic Rhinitis

Allergic Rhinitis

Canada
Chong Kun Dang Pharmaceutical
Samsung Medical Center; Asan Medical Center; Seoul National University Hospital; Ulsan University Hospital

Completed

Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy

Carcinoma, Non-Small-Cell Lung
University of Oxford
Cancer Research UK; Guy's and St Thomas' NHS Foundation Trust; NHS Lothian; National... and other collaborators

Completed

Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC (ARCADIAN)

Locally Advanced Non-Small Cell Lung Cancer

United Kingdom
Massachusetts General Hospital
Food and Drug Administration (FDA); Center for Psychiatry And Behavioral Medicine...

Completed

PK/PD Pediatric ADHD Classroom Study

Attention Deficit Hyperactivity Disorder

United States
Merck Sharp & Dohme LLC

Completed

PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)

Mycoses
Ove Andersen
University of Copenhagen

Completed

Development of a New Method for Analgesia

Analgesia

Denmark
Hospices Civils de Lyon
Novartis

Unknown

Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patients (PETALs)

Chronic Myeloid Leukemia

France
University of Pittsburgh
National Cancer Institute (NCI)

Completed

Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Aragon Pharmaceuticals, Inc.

Active, not recruiting

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms | Metastatic Castration-Resistant Prostate Cancer

United States, Canada, Netherlands, United Kingdom
Jennifer Woyach

Active, not recruiting

Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
NewVac LLC
Janssen Pharmaceutica N.V., Belgium

Completed

Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Epithelial Ovarian Cancer | Non-small Cell Lung Cancer

Russian Federation
Maastricht University Medical Center

Not yet recruiting

The OPTIMISE Study

Intraocular Pressure | Fuchs' Endothelial Dystrophy | Pseudophakic Bullous Keratopathy
University of Pennsylvania
Alkermes, Inc.

Recruiting

Naltrexone in AUD Reward Drinkers

Alcoholism | Alcohol Use Disorder

United States
Indiana University

Completed

Gabapentin to Improve Patient Tolerance in Endoscopic Retrograde Cholangiopancreatography (ERCP)

Conscious Sedation

United States
Oculis

Completed

OCS-01 in Treating Inflammation and Pain in Post-cataract Patients (SKYGGN)

Pain, Postoperative | Inflammation Corneal

United States
University Hospital of Patras

Completed

Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification

Cataract | Intraocular Pressure

Greece
University of California, Irvine

Completed

Comparing Post-Op Narcotic Usage in Patients Receiving Periarticular Exparel vs. Standard Periarticular Joint Inj

Arthroplasty, Replacement, Knee

United States
Yale University

Completed

A Double-blind Study to Determine if Intraduodenal Indomethacin Can Decrease the Incidence of Post-ERCP Pancreatitis

Pancreatitis

United States
Hospices Civils de Lyon

Unknown

RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin (RIBAJUSTE)

Chronic Hepatitis C

France

Search clinical trials for: JNJ-54175446 (suspension)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations